[Form 4] DILLARD'S, INC. Insider Trading Activity
Denise Alexandra Lucie, reported as a Vice President of Dillard's, Inc. (DDS), executed a securities transaction on 09/29/2025. The Form 4 shows an acquisition (code A) of 9 shares of Dillard's Class A common stock at a reported price of $622.50 per share, increasing her direct holdings to 37,022 shares. The filing also discloses 5,068 shares held in a retirement plan (direct) and additional indirect beneficial ownership totaling 38,423 shares held in trust where she is trustee and 13,389 shares held in children’s trusts where she is grantor, as explained in the footnotes. The form is signed and dated 10/01/2025.
Denise Alexandra Lucie, riportata come Vice President di Dillard's, Inc. (DDS), ha eseguito una operazione di titoli il 29/09/2025. Il Modulo 4 mostra un'acquisizione (codice A) di 9 azioni delle azioni ordinarie di Classe A di Dillard's al prezzo riportato di $622,50 per azione, aumentando la sua partecipazione diretta a 37.022 azioni. La dichiarazione segnala anche 5.068 azioni detenute in un piano pensionistico (dirette) e una proprietà beneficiaria indiretta aggiuntiva pari a 38.423 azioni detenute in un trust di cui è fiduciaria e 13.389 azioni detenute nei trust dei figli dove è donataria, come spiegato nelle note a piè di pagina. Il modulo è firmato e datato 01/10/2025.
Denise Alexandra Lucie, reportada como Vicepresidenta de Dillard's, Inc. (DDS), realizó una operación de valores el 29/09/2025. El Formulario 4 muestra una adquisición (código A) de 9 acciones de las acciones comunes Clase A de Dillard's a un precio informado de $622,50 por acción, incrementando su participación directa a 37.022 acciones. La declaración también revela 5.068 acciones poseídas en un plan de jubilación (directas) y una propiedad de beneficios indirecta adicional que suma 38.423 acciones poseídas en un fideicomiso donde ella es albacea y 13.389 acciones poseídas en fideicomisos de los hijos donde ella es otorgante, como se explica en las notas al pie. El formulario está firmado y fechado 01/10/2025.
Denise Alexandra Lucie가 Dillard's, Inc. (DDS)의 부사장으로 보고되었으며, 2025년 9월 29일에 증권 거래를 실행했습니다. Form 4에는 Dillard's Class A 보통주를 9주의 인수로 표시되어 있으며 보고된 주당 가격은 $622.50이고, 그녀의 보유지분은 직접 37,022주로 증가합니다. 제출 서류에는 또한 은퇴 계획(직접)에 보유된 5,068주와 그녀가 수탁자로서 보유한 신탁에서의 간접적 유익 소유가 합쳐져 38,423주이고, 그녀가 양도인인 자녀 신탁에서 보유한 13,389주가 피고지된다는 내용이 각주에 설명되어 있습니다. 서류는 2025년 10월 1일에 서명되고 날짜가 기재되어 있습니다.
Denise Alexandra Lucie, rapportée comme Vice‑Présidente de Dillard's, Inc. (DDS), a effectué une transaction sur valeurs le 29/09/2025. Le formulaire 4 indique une acquisition (code A) de 9 actions des actions ordinaires de Classe A de Dillard's à un prix déclaré de $622,50 par action, portant sa participation directe à 37 022 actions. Le dépôt divulgue également 5 068 actions détenues dans un régime de retraite (directes) et une propriété bénéficiaire indirecte supplémentaire totalisant 38 423 actions détenues en fiducie où elle est fiduciaire et 13 389 actions détenues dans les fiducies d’enfants où elle est donataire, comme expliqué dans les notes de bas de page. Le formulaire est signé et daté du 01/10/2025.
Denise Alexandra Lucie, gemeldet als Vizepräsidentin von Dillard's, Inc. (DDS), führte am 29.09.2025 eine Wertpapiertransaktion durch. Das Formular 4 zeigt eine Erwerbung (Code A) von 9 Aktien der Class‑A‑Stammaktien von Dillard's zu einem angegebenen Preis von $622,50 pro Aktie, wodurch ihre direkte Beteiligung auf 37.022 Aktien steigt. Die Einreichung gibt außerdem an, dass 5.068 Aktien in einem Altersvorsorgeplan (direkt) gehalten werden und zusätzlich indirektes wirtschaftliches Eigentum in Höhe von 38.423 Aktien in einem Trust besteht, in dem sie Treuhänderin ist, sowie 13.389 Aktien in den Kids‑Trusts, in denen sie Begünstigte ist, wie in den Fußnoten erläutert. Das Formular ist unterschrieben und datiert auf 01.10.2025.
Denise Alexandra Lucie، التي أُبلغ عنها كـ نائبة رئيسية لـ Dillard's, Inc. (DDS)، نفّذت صفقة أوراق مالية في 29/09/2025. يظهر النموذج 4 استحواذاً (رمز A) لـ 9 أسهم من أسهم ديلاردز من فئة أ بسعر مُعلن قدره $622.50 للسهم، مما زاد من حصّتها المباشرة إلى 37,022 سهماً. كما تكشف الإفادة عن 5,068 سهماً محفوظة في خطة تقاعد (مباشرة) وملكية مستفادة غير مباشرة إضافية تبلغ 38,423 سهماً محمولة في صندوق ائتماني تكون هي فيها الوصي و13,389 سهماً محمولة في صناديق ائتمانية أطفال تكون هي فيها المانحة، كما شرح في الحواشي. النموذج موقع ومؤرخ في 01/10/2025.
Denise Alexandra Lucie，被报告为 Dillard's, Inc. (DDS) 的副总裁，于2025/09/29执行了一笔证券交易。表格4显示对 A 代码 的9 股 Dillard's A 类普通股的认购，每股报道价格为$622.50，使她的直接持股增至37,022 股。申报还披露在退休计划（直接）中持有的5,068 股，以及在信托中作为受托人所持的额外间接受益所有权，总计38,423 股，以及在她是设立人（grantor）的子女信托中持有的13,389 股，如脚注所述。该表格于2025/10/01签署并注明日期。
- Insider purchase disclosed, showing continued insider ownership and compliance with Section 16 reporting
- Clear footnotes explain indirect holdings (trustee and grantor), improving transparency about beneficial ownership
- Transaction quantity is very small (9 shares), making the purchase immaterial relative to total holdings
- High per-share price reported may reflect aggregated reporting format and could confuse some readers (no explanation in form)
Insights
TL;DR: Officer purchased a small number of Class A shares, modestly increasing direct holdings; several material indirect holdings held in trusts.
The filing documents a routine insider acquisition: a purchase of 9 Class A shares at a high per-share price, which suggests a non-typical lot size or reporting of aggregated transaction value per share. Direct beneficial ownership after the transaction is disclosed as 37,022 shares, with an additional 5,068 shares in a retirement plan and significant indirect holdings through trusts (38,423 and 13,389 shares) identified in footnotes. For investors and compliance reviewers, the key points are the mix of direct and indirect ownership and the roles of trustee/grantor that create indirect beneficial ownership. The transaction size is immaterial relative to the aggregate holdings disclosed but is relevant for transparency on insider activity.
TL;DR: Disclosure aligns with Section 16 reporting: officer reports acquisition and clarifies trust holdings; transaction appears routine.
The Form 4 clearly identifies the reporting person as a company officer (Vice President) and sets out direct and indirect ownership via trusts and a retirement account. Footnotes explain the nature of indirect holdings (trustee and grantor roles). The filing includes a manual signature and date, satisfying formal requirements. There is no indication of option exercise, derivative transactions, or disposition activity. From a governance perspective, the report provides appropriate transparency about insider ownership structure without revealing any compensatory or extraordinary transactions.
Denise Alexandra Lucie, riportata come Vice President di Dillard's, Inc. (DDS), ha eseguito una operazione di titoli il 29/09/2025. Il Modulo 4 mostra un'acquisizione (codice A) di 9 azioni delle azioni ordinarie di Classe A di Dillard's al prezzo riportato di $622,50 per azione, aumentando la sua partecipazione diretta a 37.022 azioni. La dichiarazione segnala anche 5.068 azioni detenute in un piano pensionistico (dirette) e una proprietà beneficiaria indiretta aggiuntiva pari a 38.423 azioni detenute in un trust di cui è fiduciaria e 13.389 azioni detenute nei trust dei figli dove è donataria, come spiegato nelle note a piè di pagina. Il modulo è firmato e datato 01/10/2025.
Denise Alexandra Lucie, reportada como Vicepresidenta de Dillard's, Inc. (DDS), realizó una operación de valores el 29/09/2025. El Formulario 4 muestra una adquisición (código A) de 9 acciones de las acciones comunes Clase A de Dillard's a un precio informado de $622,50 por acción, incrementando su participación directa a 37.022 acciones. La declaración también revela 5.068 acciones poseídas en un plan de jubilación (directas) y una propiedad de beneficios indirecta adicional que suma 38.423 acciones poseídas en un fideicomiso donde ella es albacea y 13.389 acciones poseídas en fideicomisos de los hijos donde ella es otorgante, como se explica en las notas al pie. El formulario está firmado y fechado 01/10/2025.
Denise Alexandra Lucie가 Dillard's, Inc. (DDS)의 부사장으로 보고되었으며, 2025년 9월 29일에 증권 거래를 실행했습니다. Form 4에는 Dillard's Class A 보통주를 9주의 인수로 표시되어 있으며 보고된 주당 가격은 $622.50이고, 그녀의 보유지분은 직접 37,022주로 증가합니다. 제출 서류에는 또한 은퇴 계획(직접)에 보유된 5,068주와 그녀가 수탁자로서 보유한 신탁에서의 간접적 유익 소유가 합쳐져 38,423주이고, 그녀가 양도인인 자녀 신탁에서 보유한 13,389주가 피고지된다는 내용이 각주에 설명되어 있습니다. 서류는 2025년 10월 1일에 서명되고 날짜가 기재되어 있습니다.
Denise Alexandra Lucie, rapportée comme Vice‑Présidente de Dillard's, Inc. (DDS), a effectué une transaction sur valeurs le 29/09/2025. Le formulaire 4 indique une acquisition (code A) de 9 actions des actions ordinaires de Classe A de Dillard's à un prix déclaré de $622,50 par action, portant sa participation directe à 37 022 actions. Le dépôt divulgue également 5 068 actions détenues dans un régime de retraite (directes) et une propriété bénéficiaire indirecte supplémentaire totalisant 38 423 actions détenues en fiducie où elle est fiduciaire et 13 389 actions détenues dans les fiducies d’enfants où elle est donataire, comme expliqué dans les notes de bas de page. Le formulaire est signé et daté du 01/10/2025.
Denise Alexandra Lucie, gemeldet als Vizepräsidentin von Dillard's, Inc. (DDS), führte am 29.09.2025 eine Wertpapiertransaktion durch. Das Formular 4 zeigt eine Erwerbung (Code A) von 9 Aktien der Class‑A‑Stammaktien von Dillard's zu einem angegebenen Preis von $622,50 pro Aktie, wodurch ihre direkte Beteiligung auf 37.022 Aktien steigt. Die Einreichung gibt außerdem an, dass 5.068 Aktien in einem Altersvorsorgeplan (direkt) gehalten werden und zusätzlich indirektes wirtschaftliches Eigentum in Höhe von 38.423 Aktien in einem Trust besteht, in dem sie Treuhänderin ist, sowie 13.389 Aktien in den Kids‑Trusts, in denen sie Begünstigte ist, wie in den Fußnoten erläutert. Das Formular ist unterschrieben und datiert auf 01.10.2025.
FAQ
What did the DDS insider file disclose on 09/29/2025?
How many DDS shares does the reporting person beneficially own after the transaction?
Does the Form 4 disclose indirect holdings for DDS (symbol DDS)?
Are there any derivative or option transactions reported in this Form 4 for DDS?
Was the Form 4 properly signed and dated?
